Navigation Links
First Boston Pharma, LLC Acquires NutraMax Products, Inc.
Date:5/13/2009

GLOUCESTER, Mass., May 13 /PRNewswire/ -- First Boston Pharma announces the acquisition of NutraMax, Products, Inc., a contract manufacturer of solid dose and soft chew pharmaceuticals and supplements. The company will now be known as First Boston Pharma, LLC.

Leading the First Boston Pharma organization is Mario Medri, one of the industry's foremost innovators in over-the-counter ("OTC") drugs and supplement formulations. With over 40 years of experience in the consumer packaging goods industry, Medri has developed a multitude of products in the OTC drug and supplements categories, as well as flavors, fragrances, confections, foods and cosmetics. He holds over 15 product and process patents. Medri's many contributions to the market include inventing soft chews as a vehicle for delivery of OTC drugs and supplements and developing new products and technologies for pectin/menthol cough drops, honey liquid center cough drops and liquid center throat lozenges.

"The acquisition by Mario and the First Boston Pharma Group will propel the company further and faster along the trajectory we are on, particularly with designer products for pharmaceuticals and supplement markets," says Rodney Plunkett, Executive Vice President of First Boston Pharma. "To have the industry's foremost innovator leading First Boston Pharma into the future is an exciting prospect for us and for our customers," adds Plunkett.

The acquisition of NutraMax by First Boston Pharma will provide the necessary resources for the company to pursue its strategy of innovation in the over-the-counter drugs and supplements categories. The company will drive its growth strategy though investment in additional R&D, and in unique production capabilities. "One of our key strategies is to move to a supply base integrity model, which gives our customers the differentiated products they need, when they want them," says Medri.

About First Boston Pharma, LLC:

First Boston Pharma, LLC is a contract manufacturer of solid dose, soft chew, liquid, tablet and chewing gum based pharmaceuticals and supplements servicing branded companies and retailer private label products. The company provides turnkey services to customers wishing to introduce new products from product ideation to R&D, product development to production. Headquartered in Gloucester, MA, First Boston Pharma has an additional facility in Brockton, MA. All facilities are FDA registered drug manufacturing sites, and also cGMP and DSHEA compliant. For more information, visit www.Firstbostonpharma.com

LINKS

Mario Medri mmedri@1stbp.com

Rodney Plunkett rplunkett@1stbp.com

First Boston Pharma, LLC www.firstbostonpharma.com


'/>"/>
SOURCE First Boston Pharma, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Super Lice Repelled by All-Natural Products First Ever Independent Study Shows
2. AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure
3. China Medicine Announces First Quarter 2009 Results
4. Amilpar - Revenue Increases 13.4% and Medical Loss Ratio Falls in the First Quarter 2009
5. Pharmos Corporation Reports 2009 First Quarter Results
6. Pregis Announces First Quarter 2009 Financial Results
7. Access to care leads Americans priorities in first-ever public study of health value
8. Access to Care Leads Americans Priorities in First-Ever Public Study of Health Value
9. The Nielsen Company Launches First-Ever CLIO Healthcare Awards Acknowledging Creative Excellence in Healthcare Communications
10. Advanced Life Sciences Announces First Quarter 2009 Financial Results and Financial Outlook
11. Boston Scientific Announces European Approval and First Implants of New Defibrillation Lead System Designed to Simplify the Surgical Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, ... Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility ... home to some of the world’s leading providers of cereal and other breakfast foods. ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
Breaking Medicine Technology: